查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1855928

2025年全球分子腫瘤學板解決方案市場報告

Molecular Tumor Board Solutions Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，分子腫瘤委員會解決方案市場規模快速成長，從2024年的13.4億美元成長到2025年的15.3億美元，複合年成長率達13.9%。這一成長趨勢的促進因素包括基因組分析技術的日益普及、精準腫瘤學需求的成長、分子診斷意識的提高、癌症研究舉措的拓展以及醫院與生物技術公司之間合作的加強。

預計未來幾年分子腫瘤委員會解決方案市場將快速成長，到2029年市場規模將達到25.3億美元，複合年成長率（CAGR）為13.5%。預測期內的成長主要受以下因素驅動：對多學科腫瘤委員會的需求不斷成長、雲端基礎的分子數據平台不斷擴展、基因組檢測監管支持力度加大、以患者為中心的腫瘤治療日益受到重視以及癌症發病率不斷上升。預測期內的主要趨勢包括：基因測序工具的進步、分子解決方案研發投入的增加、臨床決策支援軟體的創新、數據分析和視覺化技術的改進以及機器學習在治療建議中的應用。

分子腫瘤委員會解決方案是先進的平台，旨在透過整合詳細的患者特異性分子和基因組資訊，協助多學科臨床團隊分析癌症病例。這些解決方案能夠識別可操作的基因變化、評估標靶治療方案並審查相關的臨床試驗，從而促進知情且個人化的治療決策。

分子腫瘤委員會解決方案的主要組成部分是軟體和服務。軟體包括數位平台和應用程式，用於整合患者數據、分析基因譜並提供癌症治療提案。這些解決方案可部署在本地或雲端基礎系統，應用於臨床決策支援、基因組資料解讀和病患管理等領域。主要最終用戶包括醫院、癌症中心、研究機構和其他醫療機構。

美國在2025年春季突然提高關稅，由此引發的貿易摩擦對醫療保健產業造成了嚴重衝擊，尤其對關鍵醫療設備、診斷試劑和藥品的供應造成了嚴重影響。醫院和醫療機構面臨進口手術器械、影像設備以及注射器、導管等耗材成本不斷上漲的困境。這些成本的增加加劇了醫療預算的緊張，導致一些醫療機構必須推遲設備升級或將成本轉嫁給患者。此外，原料和零件的關稅也阻礙了必需藥品和醫療設備的生產，造成供應鏈瓶頸。為了應對這項挑戰，醫療產業正在積極調整籌資策略，盡可能地促進本地生產，並呼籲對緊急醫療產品實施關稅豁免。

本研究報告是商業研究公司（The Business Research Company）最新系列報告的一部分，提供分子腫瘤板解決方案市場統計數據，包括全球市場規模、區域佔有率、競爭對手及其市場佔有率、詳細的市場細分、市場趨勢和商機，以及您在分子腫瘤板解決方案行業取得成功所需的數據。本分子腫瘤板解決方案市場研究報告對該行業的現狀和未來發展趨勢進行了詳細分析，為您提供所需的一切觀點。

預計未來幾年，癌症發生率的不斷上升將推動分子腫瘤委員會解決方案市場的成長。癌症是一組以體內異常細胞不受控制地生長和擴散為特徵的疾病。癌症發生率的上升歸因於不良飲食、吸煙、缺乏運動和過度飲酒等生活方式因素。分子腫瘤委員會解決方案透過提供專家對患者基因組和臨床數據的多學科審查，為癌症治療提供支持，並幫助制定個人化的治療方案。透過整合分子譜分析和人工智慧主導的洞察，這些解決方案可以增強臨床決策，提高治療的準確性和患者預後。例如，英國國家醫療服務體系 (NHS) 在 2024 年 10 月報告稱，2022 年新增癌症病例增加了 5%，從 2021 年的 329,664 例增加到 346,217 例，平均每天新增 948 例。因此，癌症發生率的上升正在推動分子腫瘤委員會解決方案市場的成長。

分子腫瘤活體組織切片解決方案市場的企業正致力於開發創新的分子譜分析檢測方法，以提高癌症診斷和治療方案製定的準確性和有效性。分子譜分析檢測透過分析腫瘤的​​遺傳和分子特徵來指導個體化治療決策。例如，專注於精準腫瘤學的美國生物技術公司Guardant Health Inc.於2025年4月推出了Guardant360 Tissue，這是一款先進的腫瘤組織分子譜分析檢測。此檢測整合了全面的多組學分析，包括DNA、RNA、人工智慧驅動的PD-L1以及全基因組甲基化數據。 Guardant360 Tissue基於Guardant Infinity智慧液態切片平台，能夠提供更全面的癌症資訊，從而實現更精準的腫瘤分類和亞型分析。檢測結果可在兩週內獲得，合格的患者可享有聯邦醫療保險（Medicare）的報銷。該檢測旨在透過提供有價值的資訊來增強精準腫瘤學，從而指導包括PARP抑制劑和免疫療法在內的各種治療決策。

2024年9月，美國醫療保健公司LabCorp Holdings Inc.以2.375億美元收購了BioReference Health LLC。此次收購使LabCorp能夠擴展其檢測服務網路，並增加重點地區患者、醫生和客戶獲得臨床檢測的機會。 BioReference Health LLC專注於分子腫瘤委員會解決方案，提供全面的基因組檢測和廣泛的診斷測試。

分子腫瘤委員會解決方案市場包括營業單位透過向醫療服務提供者和患者提供專業臨床諮詢、個人化治療提案和決策支援服務而產生的收入。市場價值還包括服務提供者銷售的或包含在其服務產品中的相關商品的價值。僅包括在營業單位間交易或銷售給最終消費者的商品和服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球分子腫瘤委員會解決方案：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 終端用戶產業分析
  • 全球分子腫瘤委員會解決方案市場：成長率分析
  • 全球分子腫瘤委員會解決方案市場表現：規模與成長，2019-2024年
  • 全球分子腫瘤委員會解決方案市場預測：規模與成長，2024-2029年，2034年預測
  • 全球分子腫瘤委員會解決方案：潛在市場規模 (TAM)

第6章 市場細分

  • 全球分子腫瘤板解決方案市場：按組件分類，實際值和預測值，2019-2024年、2024-2029年預測值、2034年預測值
  • 軟體
  • 服務
  • 全球分子腫瘤板解決方案市場：依部署模式分類，實際值及預測值，2019-2024年、2024-2029年預測值、2034年預測值
  • 本地部署
  • 雲端基礎的
  • 全球分子腫瘤板解決方案市場：按應用領域分類，實際結果與預測，2019-2024年、2024-2029年預測、2034年預測
  • 臨床決策支持
  • 基因組數據解讀
  • 病患管理
  • 其他用途
  • 全球分子腫瘤板解決方案市場：依最終用戶分類，實際值和預測值，2019-2024年、2024-2029年預測值、2034年預測值
  • 醫院
  • 癌症中心
  • 研究所
  • 其他最終用戶
  • 全球分子腫瘤學板解決方案市場：按軟體、類型、實際值和預測值細分，2019-2024年、2024-2029年預測值、2034年預測值
  • 臨床決策支持
  • 數據分析
  • 彙報和可視化
  • 整合平台
  • 全球分子腫瘤委員會解決方案市場：按服務、類型、實際值和預測值細分，2019-2024年、2024-2029年預測值、2034年預測值
  • 諮詢
  • 執行
  • 培訓和支持
  • 維護和升級

第7章 區域和國家分析

  • 全球分子腫瘤學板解決方案市場：按地區分類，實際結果和預測，2019-2024年、2024-2029年預測、2034年預測
  • 全球分子腫瘤板解決方案市場：國家/地區、績效及預測，2019-2024年、2024-2029年預測、2034年預測

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 分子腫瘤委員會解決方案市場：競爭格局
  • 分子腫瘤委員會解決方案市場：公司簡介
    • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Novogene Co. Ltd.
  • QIAGEN NV
  • Myriad Genetics Inc.
  • BGI Genomics Co. Ltd.
  • Guardant Health Inc.
  • Caris Life Sciences Inc.
  • Mayo Clinic Laboratories
  • Sectra AB
  • GenomOncology LLC
  • MedGenome Labs Ltd.
  • Burning Rock Biotech Limited
  • NantHealth Inc.
  • SOPHiA GENETICS SA
  • Variantyx Inc.
  • Baylor Genetics

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年分子腫瘤委員會解決方案市場：提供新機會的國家
  • 2029年分子腫瘤委員會解決方案市場：提供新機會的細分市場
  • 2029年分子腫瘤委員會解決方案市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r38580

Molecular tumor board solutions are advanced platforms designed to support multidisciplinary clinical teams in analyzing cancer cases by integrating detailed patient-specific molecular and genomic information. These solutions enable the identification of actionable genetic mutations, evaluation of targeted therapy options, and discussion of relevant clinical trials, thereby facilitating informed and personalized treatment decisions.

The primary components of molecular tumor board solutions are software and services. Software includes digital platforms and applications that integrate patient data, analyze genetic profiles, and provide treatment recommendations for cancer care. These solutions can be deployed via on-premises or cloud-based systems and are applied in areas such as clinical decision support, genomic data interpretation, and patient management. Key end users include hospitals, cancer centers, research institutes, and other healthcare organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The molecular tumor board solutions market research report is one of a series of new reports from The Business Research Company that provides molecular tumor board solutions market statistics, including molecular tumor board solutions industry global market size, regional shares, competitors with a molecular tumor board solutions market share, detailed molecular tumor board solutions market segments, market trends and opportunities, and any further data you may need to thrive in the molecular tumor board solutions industry. This molecular tumor board solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The molecular tumor board solutions market size has grown rapidly in recent years. It will grow from $1.34 billion in 2024 to $1.53 billion in 2025 at a compound annual growth rate (CAGR) of 13.9%. The growth during the historic period was driven by increasing adoption of genomic profiling, rising demand for precision oncology, growing awareness of molecular diagnostics, expansion of cancer research initiatives, and increasing collaborations between hospitals and biotech firms.

The molecular tumor board solutions market size is expected to see rapid growth in the next few years. It will grow to $2.53 billion in 2029 at a compound annual growth rate (CAGR) of 13.5%. The growth during the forecast period is fueled by rising demand for multidisciplinary tumor boards, expansion of cloud-based molecular data platforms, increasing regulatory support for genomic testing, greater focus on patient-centric oncology care, and rising incidence of cancer cases. The primary trends in the forecast period include advancements in genomic sequencing tools, increased investment in research and development for molecular solutions, innovation in clinical decision support software, improvements in data analytics and visualization, and integration of machine learning for treatment recommendations.

The increasing prevalence of cancer is expected to drive the growth of the molecular tumor board solutions market in the coming years. Cancer is a group of diseases marked by the uncontrolled growth and spread of abnormal cells in the body. The rising incidence of cancer can be attributed to lifestyle factors such as poor diet, smoking, lack of physical activity, and excessive alcohol consumption. Molecular tumor board solutions support cancer care by offering expert, multidisciplinary reviews of patients' genomic and clinical data, helping to develop personalized treatment plans. By integrating molecular profiling with AI-driven insights, these solutions enhance clinical decision-making, improving treatment precision and patient outcomes. For example, in October 2024, the National Health Service (NHS) reported a 5% increase in new cancer diagnoses, from 329,664 cases in 2021 to 346,217 in 2022, averaging 948 new cases per day. As a result, the rising cancer prevalence is contributing to the growth of the molecular tumor board solutions market.

Companies in the molecular tumor board solutions market are focusing on developing innovative molecular profiling tests to improve the accuracy and effectiveness of cancer diagnostics and treatment planning. Molecular profiling tests analyze a tumor's genetic and molecular features to guide personalized treatment decisions. For example, in April 2025, Guardant Health Inc., a US-based biotechnology company specializing in precision oncology, launched Guardant360 Tissue, an advanced molecular profiling test for tumor tissue. This test incorporates comprehensive multiomic analysis, including DNA, RNA, AI-powered PD-L1, and genome-wide methylation data. Powered by the Guardant Infinity smart liquid biopsy platform, Guardant360 Tissue offers a more complete view of cancer, enabling more accurate tumor classification and subtyping. Results are delivered in less than two weeks, and the test is covered by Medicare for eligible patients. It aims to enhance precision oncology by providing valuable insights to guide treatment decisions, including therapies such as PARP inhibitors and immunotherapies.

In September 2024, Labcorp Holdings Inc., a US-based healthcare company, acquired BioReference Health LLC for $237.5 million. This acquisition enables Labcorp to expand its laboratory services network and broaden access to clinical testing for patients, physicians, and customers in key regions. BioReference Health LLC specializes in molecular tumor board solutions, offering comprehensive genomic testing and a wide range of diagnostic tests.

Major players in the molecular tumor board solutions market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Koninklijke Philips N.V., Illumina Inc., Novogene Co. Ltd., QIAGEN N.V., Myriad Genetics Inc., BGI Genomics Co. Ltd., Guardant Health Inc., Caris Life Sciences Inc., Mayo Clinic Laboratories, Sectra AB, GenomOncology LLC, MedGenome Labs Ltd., Burning Rock Biotech Limited, NantHealth Inc., SOPHiA GENETICS SA, Variantyx Inc., Baylor Genetics, Molecular Health GmbH, PierianDx Inc., Oncompass Medicine, and CureMatch Inc.

North America was the largest region in the molecular tumor board solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in molecular tumor board solutions report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the molecular tumor board solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The molecular tumor board solutions market includes revenues earned by entities through providing expert clinical consultations, personalized treatment recommendations, and decision-support services to healthcare providers and patients. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Molecular Tumor Board Solutions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on molecular tumor board solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for molecular tumor board solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The molecular tumor board solutions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: Software; Services
  • 2) By Deployment Mode: On-Premises; Cloud-Based
  • 3) By Application: Clinical Decision Support; Genomic Data Interpretation; Patient Management; Other Applications
  • 4) By End-User: Hospitals; Cancer Centers; Research Institutes; Other End-Users
  • Subsegments:
  • 1) By Software: Clinical Decision Support; Data Analytics; Reporting And Visualization; Integration Platforms
  • 2) By Services: Consulting; Implementation; Training And Support; Maintenance And Upgrades
  • Companies Mentioned: F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Siemens Healthineers AG; Koninklijke Philips N.V.; Illumina Inc.; Novogene Co. Ltd.; QIAGEN N.V.; Myriad Genetics Inc.; BGI Genomics Co. Ltd.; Guardant Health Inc.; Caris Life Sciences Inc.; Mayo Clinic Laboratories; Sectra AB; GenomOncology LLC; MedGenome Labs Ltd.; Burning Rock Biotech Limited; NantHealth Inc.; SOPHiA GENETICS SA; Variantyx Inc.; Baylor Genetics; Molecular Health GmbH; PierianDx Inc.; Oncompass Medicine; CureMatch Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Molecular Tumor Board Solutions Market Characteristics

3. Molecular Tumor Board Solutions Market Trends And Strategies

4. Molecular Tumor Board Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Molecular Tumor Board Solutions Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Molecular Tumor Board Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Molecular Tumor Board Solutions Market Growth Rate Analysis
  • 5.4. Global Molecular Tumor Board Solutions Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Molecular Tumor Board Solutions Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Molecular Tumor Board Solutions Total Addressable Market (TAM)

6. Molecular Tumor Board Solutions Market Segmentation

  • 6.1. Global Molecular Tumor Board Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software
  • Services
  • 6.2. Global Molecular Tumor Board Solutions Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • On-Premises
  • Cloud-Based
  • 6.3. Global Molecular Tumor Board Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinical Decision Support
  • Genomic Data Interpretation
  • Patient Management
  • Other Applications
  • 6.4. Global Molecular Tumor Board Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Cancer Centers
  • Research Institutes
  • Other End-Users
  • 6.5. Global Molecular Tumor Board Solutions Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinical Decision Support
  • Data Analytics
  • Reporting And Visualization
  • Integration Platforms
  • 6.6. Global Molecular Tumor Board Solutions Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consulting
  • Implementation
  • Training And Support
  • Maintenance And Upgrades

7. Molecular Tumor Board Solutions Market Regional And Country Analysis

  • 7.1. Global Molecular Tumor Board Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Molecular Tumor Board Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Molecular Tumor Board Solutions Market

  • 8.1. Asia-Pacific Molecular Tumor Board Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Molecular Tumor Board Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Molecular Tumor Board Solutions Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Molecular Tumor Board Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Molecular Tumor Board Solutions Market

  • 9.1. China Molecular Tumor Board Solutions Market Overview
  • 9.2. China Molecular Tumor Board Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Molecular Tumor Board Solutions Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Molecular Tumor Board Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Molecular Tumor Board Solutions Market

  • 10.1. India Molecular Tumor Board Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Molecular Tumor Board Solutions Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Molecular Tumor Board Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Molecular Tumor Board Solutions Market

  • 11.1. Japan Molecular Tumor Board Solutions Market Overview
  • 11.2. Japan Molecular Tumor Board Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Molecular Tumor Board Solutions Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Molecular Tumor Board Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Molecular Tumor Board Solutions Market

  • 12.1. Australia Molecular Tumor Board Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Molecular Tumor Board Solutions Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Molecular Tumor Board Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Molecular Tumor Board Solutions Market

  • 13.1. Indonesia Molecular Tumor Board Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Molecular Tumor Board Solutions Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Molecular Tumor Board Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Molecular Tumor Board Solutions Market

  • 14.1. South Korea Molecular Tumor Board Solutions Market Overview
  • 14.2. South Korea Molecular Tumor Board Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Molecular Tumor Board Solutions Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Molecular Tumor Board Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Molecular Tumor Board Solutions Market

  • 15.1. Western Europe Molecular Tumor Board Solutions Market Overview
  • 15.2. Western Europe Molecular Tumor Board Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Molecular Tumor Board Solutions Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Molecular Tumor Board Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Molecular Tumor Board Solutions Market

  • 16.1. UK Molecular Tumor Board Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Molecular Tumor Board Solutions Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Molecular Tumor Board Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Molecular Tumor Board Solutions Market

  • 17.1. Germany Molecular Tumor Board Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Molecular Tumor Board Solutions Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Molecular Tumor Board Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Molecular Tumor Board Solutions Market

  • 18.1. France Molecular Tumor Board Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Molecular Tumor Board Solutions Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Molecular Tumor Board Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Molecular Tumor Board Solutions Market

  • 19.1. Italy Molecular Tumor Board Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Molecular Tumor Board Solutions Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Molecular Tumor Board Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Molecular Tumor Board Solutions Market

  • 20.1. Spain Molecular Tumor Board Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Molecular Tumor Board Solutions Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Molecular Tumor Board Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Molecular Tumor Board Solutions Market

  • 21.1. Eastern Europe Molecular Tumor Board Solutions Market Overview
  • 21.2. Eastern Europe Molecular Tumor Board Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Molecular Tumor Board Solutions Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Molecular Tumor Board Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Molecular Tumor Board Solutions Market

  • 22.1. Russia Molecular Tumor Board Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Molecular Tumor Board Solutions Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Molecular Tumor Board Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Molecular Tumor Board Solutions Market

  • 23.1. North America Molecular Tumor Board Solutions Market Overview
  • 23.2. North America Molecular Tumor Board Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Molecular Tumor Board Solutions Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Molecular Tumor Board Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Molecular Tumor Board Solutions Market

  • 24.1. USA Molecular Tumor Board Solutions Market Overview
  • 24.2. USA Molecular Tumor Board Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Molecular Tumor Board Solutions Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Molecular Tumor Board Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Molecular Tumor Board Solutions Market

  • 25.1. Canada Molecular Tumor Board Solutions Market Overview
  • 25.2. Canada Molecular Tumor Board Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Molecular Tumor Board Solutions Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Molecular Tumor Board Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Molecular Tumor Board Solutions Market

  • 26.1. South America Molecular Tumor Board Solutions Market Overview
  • 26.2. South America Molecular Tumor Board Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Molecular Tumor Board Solutions Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Molecular Tumor Board Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Molecular Tumor Board Solutions Market

  • 27.1. Brazil Molecular Tumor Board Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Molecular Tumor Board Solutions Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Molecular Tumor Board Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Molecular Tumor Board Solutions Market

  • 28.1. Middle East Molecular Tumor Board Solutions Market Overview
  • 28.2. Middle East Molecular Tumor Board Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Molecular Tumor Board Solutions Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Molecular Tumor Board Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Molecular Tumor Board Solutions Market

  • 29.1. Africa Molecular Tumor Board Solutions Market Overview
  • 29.2. Africa Molecular Tumor Board Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Molecular Tumor Board Solutions Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Molecular Tumor Board Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Molecular Tumor Board Solutions Market Competitive Landscape And Company Profiles

  • 30.1. Molecular Tumor Board Solutions Market Competitive Landscape
  • 30.2. Molecular Tumor Board Solutions Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Molecular Tumor Board Solutions Market Other Major And Innovative Companies

  • 31.1. Novogene Co. Ltd.
  • 31.2. QIAGEN N.V.
  • 31.3. Myriad Genetics Inc.
  • 31.4. BGI Genomics Co. Ltd.
  • 31.5. Guardant Health Inc.
  • 31.6. Caris Life Sciences Inc.
  • 31.7. Mayo Clinic Laboratories
  • 31.8. Sectra AB
  • 31.9. GenomOncology LLC
  • 31.10. MedGenome Labs Ltd.
  • 31.11. Burning Rock Biotech Limited
  • 31.12. NantHealth Inc.
  • 31.13. SOPHiA GENETICS SA
  • 31.14. Variantyx Inc.
  • 31.15. Baylor Genetics

32. Global Molecular Tumor Board Solutions Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Molecular Tumor Board Solutions Market

34. Recent Developments In The Molecular Tumor Board Solutions Market

35. Molecular Tumor Board Solutions Market High Potential Countries, Segments and Strategies

  • 35.1 Molecular Tumor Board Solutions Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Molecular Tumor Board Solutions Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Molecular Tumor Board Solutions Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer